Patent details

Basic Information

Publication number:

EP2501367

PCT Application Number:

PCT/EP/2010/006996

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107844508

PCT Publication Number:

WO/2011/060922

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Formulation for HGH and RHIGF-1 combination

French Title of Invention:

Préparation pour combinaison d'hormones de croissance humaine (HGH) et de RHIGF-1

German Title of Invention:

Formulierung für HGH- und RHIGF-1-Kombination

SPC Number:

Dates

Filing date:

17/11/2010

Grant date:

21/01/2015

EP Publication Date:

21/01/2015

PCT Publication Date:

26/05/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/09/2012

EP B1 Publication Date:

21/01/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/11/2015

Expiration date:

17/11/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/11/2010

 

 

Name:

IPSEN PHARMA S.A.S.

Address:

65, Quai Georges Gorse, 92100 Boulogne-Billancourt, France (FR)

Inventor

1

Name:

ARAKAWA Tsutomu

Address:

United States (US)

2

Name:

FAIS Fabio

Address:

France (FR)

3

Name:

RICHARD Joël

Address:

France (FR)

4

Name:

GOPINATH Enona

Address:

United States (US)

5

Name:

PARK Susan

Address:

United States (US)

Priority

Priority Number:

261859 P

Priority Date:

17/11/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/19;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages